Peter Heerma
CHIEF COMMERCIAL OFFICER · 3 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | May 5, 2026 | Sale | $46.65 | 2,174 | $101.4K | 140,684 | |
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | May 4, 2026 | Option Exercise | $0.00 | 4,250 | — | 142,858 | |
TVTX | Peter Heerma | — | May 5, 2026 | Proposed Sale | $46.65 | 2,174 | $101.4K | — | |
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | Apr 14, 2026 | Sale | $41.93 | 7,215 | $302.5K | 138,608 | |
TVTX | Peter Heerma | — | Apr 14, 2026 | Proposed Sale | $41.93 | 7,215 | $302.5K | — | |
TVTX | Peter Heerma | — | Feb 3, 2026 | Proposed Sale | $32.12 | 7,310 | $234.8K | — | |
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | Feb 3, 2026 | Sale | $32.12 | 7,310 | $234.8K | 131,823 | |
TVTX | Heerma Peter | — | Dec 24, 2025 | Proposed Sale | $40.00 | 4,980 | $199.2K | — | |
TVTX | Heerma Peter | — | Oct 31, 2025 | Proposed Sale | $35.00 | 5,591 | $195.7K | — | |
TVTX | Heerma Peter | — | Oct 28, 2025 | Proposed Sale | $30.00 | 2,662 | $79.9K | — | |
TVTX | Peter Heerma | — | May 5, 2025 | Proposed Sale | $21.05 | 1,771 | $37.3K | — | |
TVTX | Peter Heerma | — | Feb 12, 2025 | Proposed Sale | $23.53 | 2,568 | $60.4K | — | |
TVTX | PETER HEERMA | — | Feb 11, 2025 | Proposed Sale | $25.00 | 3,074 | $76.8K | — | |
TVTX | Peter Heerma | — | Feb 3, 2025 | Proposed Sale | $20.12 | 5,166 | $103.9K | — |